A CASE STUDY OF BUINESS ETHICS MANAGEMENT AT CIPLA LTD.
Submitted by – Deepti Arora Roll no. – 21/055
Apeejay School of Management
Cipla Limited is a pharmaceutical company based in Mumbai, India. Founded by nationalist Indian scientist Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories in 1935. Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions.
Founded prior to Indian independence and on the principle that India needed to become self-sufficient in supplying medicine to its people, Cipla has emphasized self-reliance and the right of all people to health and access to medicine, regardless of
…show more content…
This caused a revolution where HIV treatment became a reality for the world and millions of lives could be saved.
* During the 2005 Bird Flu epidemic, they produced an anti-flu drug within a period of 2-3 months, which would have normally taken at least 3 years to develop.
* In 2012, they made a breakthrough in reducing the prices of cancer drugs, thus making world-class medicines affordable and accessible to cancer patients.
* They are committed to addressing the unmet medical needs of the world by venturing into newer challenges in platform technologies, biotechnology and stem cells. * KEY PRODUCTS Cipla has a product range comprising antibiotics, anti-bacterial, anti-asthmatics, anthelmintics, anti-ulcerants, oncology, corticosteroids, nutritional supplements and cardiovascular drugs. The company has at least nine different prescription drugs registered with the US FDA. Active in the anti-bacterial and anti-asthmatic segments, Cipla was the first in Asia to launch a non-CFC metered dose inhaler. Cipla is famous for its cancer and HIV/AIDS treatment. BOARD OF DIRECTORS - Founder: Dr. K.A.Hamied (1898-1972) Chairman: Dr. Yusuf K Hamied Executive Vice-Chairman: Mr. M.K. Hamied Managing Director and Global Chief Executive Officer: Mr. Subhanu Saxena Whole-time Director: Mr. S. Radhakrishnan Non-Executive Directors: Dr. H.R.Manchanda Mr.
The purpose of this paper is to examine an ethical dilemma faced by a company who manufactures critical components for a pacemaker developer. The consequentialist ethical theory of utilitarianism will be used to evaluate the moral implications this company has in continuing further manufacturing for their pacemaker client. An overview of utilitarian ethics will be discussed, focused primarily around 17th century philosopher Jeremy Bentham’s ideas about ethics. His framework will be used to present factors that influence the transistor company’s business decision. Finally, the Utility Test and Common Good Test will be applied to the company’s predicament to help determine the correct ethical course of action for this
MEDA AB is an international specialty pharmaceutical organization with its headquarters set in Stockholm, Sweden. MEDA specializes is offering cost effective pharmaceuticals in areas such as respiratory, cardiology, dermatology, pain and inflammation, central nervous system (CNS), and over-the-counter (OTC) medicines (MEDA AB, 2012, p. 18). MEDA’s vision is to “become a world-leading specialty pharma company with a focus on sustainable and profitable growth to provide value for our patients, shareholders and other stakeholders” (MEDA AB, 2014, para. 1). MEDA is currently present in
It is often cited that the HIV/Aids epidemic that hit the United States in the 1980’s (though there is some evidence that it started even before then), came into light due to several high profile incidents and the eventual loss of several thousand lives. Many believe that due to
It wasn’t until 1989 that scientists discovered the presence of HIV in the blood in AIDS patients. Scientists then transferred their efforts towards treating HIV. This spurred a research on a global scale as this breakthrough in the now HIV/AIDS epidemic has come to the light. The now FDA and CDC were major
In this brief response to the business ethics case study, I will highlight findings that question the integrity of Next Step Herbal Health Company according to Ramona Alexander’s research on the company and her observations of the CEO’s engagement and the recruiter’s response to her raised concerns. There were three major issues I found that were questionable in making a final decision of accepting any offers from Next Step. I will elaborate on the following points:
We're one of the biggest disease focuses on the planet. We've been attempting to dispose of malignancy for over six decades. Our profundity of experience adds to each part of your consideration.
Going by history, a greater percentage of Ciba-Geigy 's sales came from the pharmaceutical divisions. The previous year in 1982 pharma division contributed to a whole 30% of the entire group’s sales with a revenue base of 4.1 billion Swiss francs making it the second-largest pharmaceutical firm in the whole globe. Pharma operated majorly in four areas namely analgesics and antirheumatics (23% of sales) not excluding Voltaren, cardiovascular products (30%) with the inclusion of beta blockers, drugs for treating epilepsy and antidepressants (15%) and antibiotics together with other drugs. Pharma also included OTC drugs, a contact lens business, and a servipharm division specifically operating to meet the demands of the developing countries.
Burroughs Wellcome is located in England. Their primary business is selling human healthcare products, prescription and nonprescription. The two main
Cambridge Sciences Pharmaceuticals (CSP) is an international healthcare company based in Cambridge, Massachusetts. The firm focuses on developing, manufacturing and marketing products that treat metabolic disorders, gastrointestinal diseases, immune deficiencies, as well as other chronic medical conditions. In 2008, CSP received its Food and Drug Administration (FDA) approval for its newest prescription drug, Metabical. Metabical is a drug that offers moderately overweight adults a medically proven, effective method to reach a desirable weight to improve their overall health by shedding ten to thirty pounds.
Ethical dilemmas are virtually impossible to avoid if you are a participant in the workforce. The definition of an ethical dilemma stands as a situation that challenges two or more “right” values that arise in a conflict (Treviño & Nelson, 2014). As ethical persons, how may we overcome ethical dilemmas and finish on the “right” side? The research mentioned in Trevino’s and Nelson’s book, “Managing Business Ethics: Straight Talk About How to Do It Right,” suggests that preparing for specific ethical challenges before a situation occurs can adequately prepare the workforce to better handle real-world applications when an ethical situation transpires. The notion that ethics is teachable inspires the following case analysis. The case analysis involving chemical safety will discuss the facts and issues, stakeholders, decision alternatives, and real-work constraints. Focusing on each of the previously mentioned topics, I will describe the applications using Utilitarian, Kantian Ethics, and Rawlsian Justice Analysis’s.
Traits associated to a psychopath include irresponsibility, manipulation, grandioseness, lack of empathy, asocial tendencies, inability to feel remorse, refusal to take responsibility for one's actions and superficial relations with others. Modern day corporations display every one of the previously listed characteristics. Is it right that an institution, whose power now rivals that of the State that once created it to seek the better welfare of its citizens, display the psychological traits of a dangerous personality disorder? Many say no: there is a rising discomfort with the corporation and its pervasion into every sphere of human life and it is this uneasiness that has prompted many academics to further study the corporation and its
Pfizer Inc is a multinational investment company. It ventures in the medical and pharmaceutical industry. It is renowned as a giant pharmaceutical company, founded in 1849. It is based in the United States, New York, Manhattan at Midtown. It is the largest universal producer and trader of pharmaceuticals (Turner, 2005, pg 161). Some of the products availed to the market by the company are Lipitor, Lyrica, Diflucan, Zithromax, Zoloft, Viagra and Celebrex. These products are targeted to patients and persons in need of enhancements in their body systems and anatomy. It has an employee capacity of 12000 people in all its departmental sectors and sub-branches. The sub-branches are distributed all over and in all continents (Turner, 2005, pg 163).
This case study was a powerful example to illustrate the presence of ethics within the
AstraZeneca has a vision of becoming a company which is most valued by businesses, customers and patients. The company also has a mission of establishing medicines with a main and purpose of treating and curing diseases, sufferings and symptoms. The company was founded by two cousins in the year 1849 and in the year 1900 it was converted from a business of the family to incorporation. In addition in the year 1944 it became the leading producer of penicillin and citric acid (Thayer 92).
Spurred on by that fact, Yusuf Hamied, chairman and managing director of Cipla Pharmaceuticals, has steered his enterprise to the forefront of global pharmaceutical development by manufacturing low-cost drugs for diseases like AIDS, diabetes and arthritis, among others.